XML 38 R27.htm IDEA: XBRL DOCUMENT
v3.22.1

Revenue from contracts with customers (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2022
Summary of disaggregates revenues by major revenue streams | The following table disaggregates Teva’s revenues by major revenue streams. For additional information on disaggregation of revenues, see note 15.
|  | Three months ended March 31, 2022 |
|  | North America |  |  | Europe |  |  | International Markets |  |  | Other activities |  |  | Total |
|  | (U.S. $ in millions) |
Sale of goods |  |  | 1,377 |  |  |  | 1,134 |  |  |  | 445 |  |  |  | 180 |  |  |  | 3,136 |
Licensing arrangements |  |  | 21 |  |  |  | 12 |  |  |  | 4 |  |  |  | 1 |  |  |  | 38 |
Distribution |  |  | 342 |  |  |  | § |  |  |  | 16 |  |  |  | — |  |  |  | 358 |
Other |  |  | (2 | ) |  |  | 9 |  |  |  | 27 |  |  |  | 95 |  |  |  | 129 |
|  | $ | 1,737 |  |  | $ | 1,156 |  |  | $ | 492 |  |  | $ | 275 |  |  | $ | 3,661 |
§ Represents an amount less than $0.5 million.
|  | Three months ended March 31, 2021 |
|  | North America |  |  | Europe |  |  | International Markets |  |  | Other activities |  |  | Total |
|  | (U.S. $ in millions) |
Sale of goods |  |  | 1,668 |  |  |  | 1,178 |  |  |  | 440 |  |  |  | 177 |  |  |  | 3,463 |
Licensing arrangements |  |  | 32 |  |  |  | 14 |  |  |  | 3 |  |  |  | 1 |  |  |  | 49 |
Distribution |  |  | 289 |  |  |  | § |  |  |  | 19 |  |  |  | — |  |  |  | 308 |
Other |  |  | § |  |  |  | 22 |  |  |  | 28 |  |  |  | 111 |  |  |  | 162 |
|  | $ | 1,989 |  |  | $ | 1,214 |  |  | $ | 490 |  |  | $ | 289 |  |  | $ | 3,982 |
§ Represents an amount less than $0.5 million.
Summary of Sales Reserves and Allowances | The changes in SR&A for third-party sales for the three months ended March 31, 2022 and 2021 were as follows:
|  | Sales Reserves and Allowances |  |  |  |
|  | Reserves included in Accounts Receivable, net |  |  | Rebates |  |  | Medicaid and other governmental allowances |  |  | Chargebacks |  |  | Returns |  |  | Other |  |  | Total reserves included in SR&A |  |  | Total |
|  | (U.S. $ in millions) |
Balance at December 31, 2021 |  | $ | 68 |  |  | $ | 1,655 |  |  | $ | 854 |  |  | $ | 1,085 |  |  | $ | 535 |  |  | $ | 112 |  |  | $ | 4,241 |  |  | $ | 4,309 |
Provisions related to sales made in current year |  |  | 82 |  |  |  | 928 |  |  |  | 198 |  |  |  | 1,814 |  |  |  | 58 |  |  |  | 90 |  |  |  | 3,088 |  |  |  | 3,170 |
Provisions related to sales made in prior periods |  |  | — |  |  |  | (90 | ) |  |  | 26 |  |  |  | (8 | ) |  |  | (14 | ) |  |  | (1 | ) |  |  | (87 | ) |  |  | (87 | )
Credits and payments |  |  | (88 | ) |  |  | (1,037 | ) |  |  | (270 | ) |  |  | (1,940 | ) |  |  | (110 | ) |  |  | (73 | ) |  |  | (3,430 | ) |  |  | (3,518 | )
Translation differences |  |  | — |  |  |  | (3 | ) |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | (5 | ) |  |  | (5 | )
Balance at March 31, 2022 |  | $ | 62 |  |  |  | 1,453 |  |  | $ | 807 |  |  | $ | 951 |  |  | $ | 469 |  |  | $ | 127 |  |  | $ | 3,807 |  |  | $ | 3,869 |
|  | Reserves included in Accounts Receivable, net |  |  | Rebates |  |  | Medicaid and other governmental allowances |  |  | Chargebacks |  |  | Returns |  |  | Other |  |  | Total reserves included in SR&A |  |  | Total |
|  | (U.S.$ in millions) |
Balance at December 31, 2020 |  | $ | 80 |  |  | $ | 2,054 |  |  | $ | 828 |  |  | $ | 1,108 |  |  | $ | 686 |  |  | $ | 148 |  |  | $ | 4,824 |  |  | $ | 4,904 |
Provisions related to sales made in current year |  |  | 100 |  |  |  | 1,126 |  |  |  | 164 |  |  |  | 2,043 |  |  |  | 76 |  |  |  | 23 |  |  |  | 3,432 |  |  |  | 3,532 |
Provisions related to sales made in prior periods |  |  | — |  |  |  | (55 | ) |  |  | (11 | ) |  |  | 6 |  |  |  | (40 | ) |  |  | (17 | ) |  |  | (117 | ) |  |  | (117 | )
Credits and payments |  |  | (102 | ) |  |  | (1,210 | ) |  |  | (188 | ) |  |  | (1,987 | ) |  |  | (101 | ) |  |  | (40 | ) |  |  | (3,526 | ) |  |  | (3,628 | )
Translation differences |  |  | — |  |  |  | (17 | ) |  |  | (4 | ) |  |  | (3 | ) |  |  | (3 | ) |  |  | (2 | ) |  |  | (29 | ) |  |  | (29 | )
Balance at March 31, 2021 |  | $ | 78 |  |  | $ | 1,898 |  |  | $ | 789 |  |  | $ | 1,167 |  |  | $ | 618 |  |  | $ | 112 |  |  | $ | 4,584 |  |  | $ | 4,662 |

X
- Definition Tabular disclosure of sales reserves and allowances current. + References No definition available. + Details
Name: | teva_SalesReservesAndAllowancesCurrentTableTextBlock
Namespace Prefix: | teva_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration